Purchase Order HHSN269201800185P
- Not listed
- This $22,829.59 firm fixed-price federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of a variety of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products...
- This federal contract award, valued at $3,510.00, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at the NIH Clinical Center. This is a...
- This federal contract award, with an ID of 75N90019P00314, is a purchase order for $20,437.06 awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride), to the National Institutes of Health...
- This is a $22,733.47 firm fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the National Institutes of Health (NIH) Clinical Center. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH research centers. Cardinal Health 414 also provides...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $3,835.00, is a firm fixed-price purchase order for various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67. The products will be used to support nuclear...
- This federal contract award, with ID 75N90018P00478, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The $24,587.55 firm-fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $4,251.00, is a Firm Fixed Price Delivery Order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract provides radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty pharmaceuticals to support nuclear medicine, oncology, and other diagnostic imaging services at...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $22,659.68 firm fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, and others, to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 is a major supplier of radiopharmaceuticals and related...
- This federal contract award to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., is for the supply of radiopharmaceuticals to various U.S. government health agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), and National Institutes of Health (NIH). The award, valued at $136,249.45, is a delivery order under an Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network 20....
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The $7,957 Firm Fixed Price Delivery Order contract is for the supply of various radiopharmaceuticals and related products to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 is a major supplier of radiopharmaceuticals to federal agencies,...
This federal contract award is to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, valued at $21,664.10, is a firm fixed-price purchase order issued by the National Institutes of Health (NIH) Clinical Center. It is not set aside for any specific business designation. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. These products support nuclear medicine, oncology, and diagnostic imaging services at federal healthcare facilities operated by the Department of Veterans Affairs (VA), Department of Defense (DoD), and NIH. Cardinal Health 414 holds numerous Indefinite Delivery Vehicles (IDVs) with the VA, Defense Health Agency, and NIH Clinical Center, valued up to $39.8 million, for the ongoing supply of radiopharmaceuticals and related products to these agencies. The company's expertise in handling and distributing time-sensitive, radioactive medical products is crucial for supporting the government's medical imaging and patient care programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($3k) | 9/16/24 | |
| P00001 | Other Administrative Action | ($550) | 9/5/24 | |
| Not listed | Not listed | $25.0k | 1/9/18 |